Author Archives: Yedida Y Bogachkov PhD

Sustained Gains for DMD Boys Evident in SRP-9001 Trials: Sarepta

New data across clinical trials of SRP-9001 show the investigative gene therapy induces sustained functional improvements in people with Duchenne muscular dystrophy (DMD), and does so with good tolerability, Sarepta Therapeutics, its developer, announced. The company, in presenting these data, also offered more details about the recently launched and pivotal…